Immuron Ltd
IMRNNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for IMRN. That does not mean none is planned.
Get an email about IMRN's next catalysts
Track Immuron (IMRN) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 1 past
No catalysts found.
Market Overview
Stock performance and key metrics
IMM-124E
Non-alcoholic Steatohepatitis (NASH)
Travelan
Diarrhea
IMM 124-E (Hyperimmune Bovine Colostrum)
Hepatitis, Alcoholic
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
IMM-124E | Phase 2 | Non-alcoholic Steatohepatitis (NASH) | - | - |
Travelan | Phase 2 | Diarrhea | - | - |
IMM 124-E (Hyperimmune Bovine Colostrum) | Phase 2 | Hepatitis, Alcoholic | - | - |
Frequently asked questions
What is in Immuron Ltd's drug pipeline?β
CatalystAlert tracks 3 drug candidates in Immuron Ltd's (IMRN) pipeline across Phase 2. Its lead program is IMM 124-E (Hyperimmune Bovine Colostrum) (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Immuron Ltd's next FDA catalyst?β
CatalystAlert tracks every upcoming catalyst for Immuron Ltd (IMRN) β PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β each confidence-rated as confirmed, estimated or AI-detected.
How do I track IMRN biotech catalysts?β
Add IMRN to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Immuron Ltd's live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
